Prostate cancer recurrence can be accurately detected by PSMA PET/MRI Dr. Kamal Kant Kohli8 Jan 2023 2:30 PMUSA: PSMA (prostate-specific membrane antigen) PET/MRI can successfully determine whether the cancer is likely to return within two years of...
Zydus Gets CDSCO panel Nod for BE Study Of Antineoplastic Drug Relugolix Dr. Divya Colin2 Jan 2023 12:00 PMNew Delhi: In response to the drug major Zydus proposal for manufacture and market of anticancer drug Relugolix Tablets 120mg along with...
Whole-body SPECT/CT with CZT system significantly cuts scan time for metastases detection in prostate cancer Medha Baranwal20 Dec 2022 2:30 PMFinland: A recent study has found that faster acquisition techniques could cut whole-body SPECT/CT bone scan times by half to detect metastatic tumors...
Medical Bulletin 15/December/2022 Isra Zaman15 Dec 2022 8:15 AMHere are the top medical news for the day:Type 2 diabetes may be reversed by Intermittent fasting Intermittent fasting diets have become popular in...
Exercise, even in late stages of the disease suppresses growth of cancer cells Isra Zaman15 Dec 2022 4:00 AMPrevious work from ECU's Exercise Medicine Research Institute has shown men with advanced prostate cancer can change the chemical environment of...
Novartis prostate cancer therapy Pluvicto bags European Commission nod Ruchika Sharma14 Dec 2022 10:45 AM"The approval of Pluvicto by the European Commission marks a major milestone for patients with advanced prostate cancer who have few alternative...
Single-fraction stereotactic body radiotherapy promising for local prostate cancer recurrence Dr.Niharika Harsha B6 Dec 2022 2:00 PMResearchers from Germany found that even in intensively pretreated prostate cancer patients single-fraction, PSMA-PET- and mpMRI-guided focal...
Cipla unveils Leuprolide Acetate Injection Depot for advanced prostate cancer in US Ruchika Sharma29 Nov 2022 7:30 AMMumbai: Pharma major Cipla Limited and its wholly owned subsidiary Cipla USA Inc., today announced the launch of Leuprolide Acetate Injection Depot ...
High dose Estetrol curbs hot flushes and improves QOl in prostate cancer patients on ADT Dr.Niharika Harsha B22 Nov 2022 2:30 PMA new study found that high-dose fetal estrogen estetrol along with androgen deprivation therapy prevented the occurrence of hot flushes and improved...
High triglyceride levels linked with increased risk of prostate cancer: Study Medha Baranwal14 Nov 2022 2:00 PMChina: Higher triglyceride levels can increase the risk of prostate cancer (PCa), is the conclusion drawn from a recent study published in BMC...
Medical Bulletin 12/November/2022 Isra Zaman12 Nov 2022 9:15 AMHere are the top medical news for the day:Treatment without hormone blockers improves outcomes in solitary prostate cancer...
Shortened course of radiation therapy safe and effective for men with high-risk prostate cancer Dr. Kamal Kant Kohli12 Nov 2022 4:15 AMA new randomized study confirms that men with high-risk prostate cancer can be treated with five versus eight weeks of radiation therapy. The phase...
